Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Sustained Locoregional Control With Deintensified Chemoradiotherapy for HPV Oropharyngeal Carcinoma.

JAMA otolaryngology-- head & neck surgery·2026
Same author

Magnetic Resonance Imaging-Directed Stereotactic Body Radiation Therapy Microboost in Concert With Pelvic Nodal Irradiation for Prostate Cancer in the Higher-Risk Spectrum: Toxicity.

Advances in radiation oncology·2026
Same author

Navigating Variability in Prostate RT Planning: Real-Time Insights for Human-Centered CDS Design.

AMIA ... Annual Symposium proceedings. AMIA Symposium·2026
Same author

Extracellular vesicle-derived miRNA-182-5p educates macrophages towards an immunosuppressive phenotype in pancreatic cancer.

Signal transduction and targeted therapy·2026
Same author

Multi-modality imaging problem-solving for pelvic splenosis on PSMA PET in a patient with recurrent prostate cancer.

BJUI compass·2025
Same author

Urinary quality of life in patients treated with prostate SBRT with intra-prostatic boost.

Frontiers in oncology·2025

Related Experiment Video

Updated: Mar 2, 2026

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

15.1K

Radiation therapy for hepatobiliary malignancies.

Jonathan W Lischalk1, Michael C Repka1, Keith Unger1

  • 1Department of Radiation Medicine, Georgetown University Hospital, Washington, DC, USA.

Journal of Gastrointestinal Oncology
|May 9, 2017
PubMed
Summary

Advanced radiotherapy techniques like SBRT and proton therapy offer improved efficacy for hepatobiliary malignancies. These precise radiation methods enable dose escalation to tumors while sparing healthy liver tissue, enhancing treatment outcomes for inoperable patients.

Keywords:
Hepatobiliary cancercholangiocarcinoma (CC)hepatocellular carcinoma (HCC)hypofractionationproton therapystereotactic body radiation therapy (SBRT)

More Related Videos

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

1.3K
Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

6.3K

Related Experiment Videos

Last Updated: Mar 2, 2026

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy
08:54

Treatment of Liver Metastases Using an Internal Target Volume Method for Stereotactic Body Radiotherapy

Published on: May 8, 2018

15.1K
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
09:11

Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma

Published on: May 24, 2024

1.3K
Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients
05:31

Transradial Access Chemoembolization for Hepatocellular Carcinoma Patients

Published on: September 20, 2020

6.3K

Area of Science:

  • Oncology
  • Radiation Oncology
  • Hepatobiliary Medicine

Background:

  • Hepatobiliary malignancies, including hepatocellular carcinoma (HCC) and cholangiocarcinoma (CC), are aggressive diseases.
  • Many patients present with inoperable disease, complicating treatment.
  • Previous radiotherapy approaches had limited efficacy and significant liver toxicity.

Purpose of the Study:

  • To evaluate the role of advanced radiotherapy in managing hepatobiliary malignancies.
  • To highlight improvements in efficacy and toxicity profiles with modern radiation techniques.

Main Methods:

  • Review of historical and current radiotherapy techniques for hepatobiliary cancers.
  • Focus on dose escalation strategies, including stereotactic body radiation therapy (SBRT) and hypofractionated proton therapy.

Main Results:

  • Modern conformal radiotherapy allows for significant dose escalation to tumors.
  • Precise delivery spares surrounding normal liver tissue, reducing toxicity.
  • Notable improvements in treatment efficacy have been observed.

Conclusions:

  • Advanced radiotherapy techniques are crucial for locoregional control of hepatobiliary malignancies.
  • Proper integration of SBRT and proton therapy can improve outcomes for patients with these grave diagnoses.